Published in Am J Public Health on December 17, 2009
Health care reform and women's insurance coverage for breast and cervical cancer screening. Prev Chronic Dis (2012) 1.56
Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol (2012) 1.49
Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning. Cancer (2014) 1.47
Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. J Natl Cancer Inst (2014) 1.30
Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program. Cancer Epidemiol Biomarkers Prev (2012) 1.29
Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities. Cancer Epidemiol Biomarkers Prev (2012) 1.19
Using data to effectively manage a national screening program. Cancer (2014) 1.14
The National Prevention Strategy and breast cancer screening: scientific evidence for public health action. Am J Public Health (2013) 1.10
From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program. Cancer (2014) 1.02
Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population. Mayo Clin Proc (2009) 1.02
Public health national approach to reducing breast and cervical cancer disparities. Cancer (2014) 0.99
Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program. J Womens Health (Larchmt) (2012) 0.98
A multilevel research perspective on cancer care delivery: the example of follow-up to an abnormal mammogram. Cancer Epidemiol Biomarkers Prev (2012) 0.98
Determinants of breast cancer treatment delay differ for African American and White women. Cancer Epidemiol Biomarkers Prev (2013) 0.97
National Breast and Cervical Cancer Early Detection Program data validation project. Cancer (2014) 0.96
Determinants of delayed detection of cancers in Texas counties in the United States of America. Int J Equity Health (2012) 0.95
Factors influencing time to diagnosis after abnormal mammography in diverse women. J Womens Health (Larchmt) (2013) 0.91
Socioeconomic deprivation as a determinant of cancer mortality and the Hispanic paradox in Texas, USA. Int J Equity Health (2013) 0.87
Diagnosis and surgical delays in African American and white women with early-stage breast cancer. J Womens Health (Larchmt) (2015) 0.84
Quality assurance through quality improvement and professional development in the National Breast and Cervical Cancer Early Detection Program. Cancer (2014) 0.83
Impact of patient and navigator race and language concordance on care after cancer screening abnormalities. Cancer (2015) 0.83
Enhancing screening and early detection among women transitioning to Medicare from the NBCCEDP in Georgia. Cancer Causes Control (2015) 0.81
The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancer. Breast Cancer Res Treat (2013) 0.80
Transition from film to digital mammography: impact for breast cancer screening through the national breast and cervical cancer early detection program. Am J Prev Med (2015) 0.79
Time from Screening Mammography to Biopsy and from Biopsy to Breast Cancer Treatment among Black and White, Women Medicare Beneficiaries Not Participating in a Health Maintenance Organization. Womens Health Issues (2016) 0.75
Diagnostic resolution of cancer screening abnormalities at community health centers. J Health Care Poor Underserved (2012) 0.75
Using Evidence-Based Interventions to Improve Cancer Screening in the National Breast and Cervical Cancer Early Detection Program. J Public Health Manag Pract (2016) 0.75
Insurance-Based Differences in Time to Diagnostic Follow-up after Positive Screening Mammography. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Lasting Effects of the Breast and Cervical Cancer Early Detection Program on Breast Cancer Detection and Outcomes, Ohio, 2000-2009. Prev Chronic Dis (2015) 0.75
Future supply and demand for oncologists : challenges to assuring access to oncology services. J Oncol Pract (2007) 17.26
Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70
Influence of delay on survival in patients with breast cancer: a systematic review. Lancet (1999) 13.10
Primary care physicians who treat blacks and whites. N Engl J Med (2004) 12.23
Predictive margins with survey data. Biometrics (1999) 9.18
Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin (2006) 4.73
Health service access, use, and insurance coverage among American Indians/Alaska Natives and Whites: what role does the Indian Health Service play? Am J Public Health (2004) 3.40
Reported drop in mammography : is this cause for concern? Cancer (2007) 2.91
Access to specialty care and medical services in community health centers. Health Aff (Millwood) (2007) 2.63
Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care (2005) 2.25
The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health (2006) 2.20
Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat (2003) 2.14
Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer (2002) 2.03
Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control (2006) 2.02
Time to diagnosis and treatment of breast cancer: results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. Am J Public Health (2000) 2.01
Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev (2003) 1.95
Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens. J Clin Oncol (2007) 1.92
Effect of the UK government's 2-week target on waiting times in women with breast cancer in southeast England. Br J Cancer (2003) 1.80
Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer (1996) 1.76
Evaluation of common breast problems: guidance for primary care providers. CA Cancer J Clin (1998) 1.72
Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer (2007) 1.66
Breast imaging reporting and data system (BI-RADS). Radiol Clin North Am (2002) 1.64
Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States). Cancer Causes Control (2006) 1.64
Exploring the limits of the safety net: community health centers and care for the uninsured. Health Aff (Millwood) (2002) 1.52
Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04. CMAJ (2007) 1.42
Racial and ethnic disparities in breast cancer stage, treatment, and survival in the United States. Ethn Dis (2005) 1.41
The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to two major health issues for women. J Public Health Manag Pract (1996) 1.38
What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey. Cancer Epidemiol Biomarkers Prev (2004) 1.36
The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida. Am J Public Health (2005) 1.30
Treatment of local breast carcinoma in Florida: the role of the distance to radiation therapy facilities. Cancer (2006) 1.28
Low-income women with breast abnormalities: system predictors of timely diagnostic resolution. Cancer Control (2007) 1.24
Role of community risk factors and resources on breast carcinoma stage at diagnosis. Cancer (2005) 1.17
On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program. Cancer Epidemiol Biomarkers Prev (2004) 1.16
Case management in public health screening programs: the experience of the national breast and cervical cancer early detection program. J Public Health Manag Pract (2005) 1.15
Improving the concordance of mammography assessment and management recommendations. Radiology (2006) 1.15
Wait times for breast cancer care. Br J Cancer (2006) 1.14
Adequacy of communicating results from screening mammograms to African American and White women. Am J Public Health (2007) 1.08
State implementation of the Breast and Cervical Cancer Prevention and Treatment Act of 2000: a collaborative effort among government agencies. Public Health Rep (2004) 1.04
Mass screening in low-income populations: the challenges of securing diagnostic and treatment services in a national cancer screening program. J Health Polit Policy Law (2000) 1.04
Influence of direct referrals on time to diagnosis after an abnormal breast screening result. Cancer Detect Prev (2004) 1.03
Limits to the safety net: teaching hospital faculty report on their patients' access to care. Health Aff (Millwood) (2003) 1.03
Family physicians expedite diagnosis of breast disease in urban minority women. J Am Board Fam Med (2007) 1.01
Influence of abnormal screens on delays and prognostic indicators of screen-detected breast carcinoma. J Med Screen (2004) 0.93
Ambulatory care for cancer in the United States: results from two national surveys comparing visits to physicians' offices and hospital outpatient departments. J Natl Med Assoc (2007) 0.92
Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening Program. Can J Public Health (2006) 0.87
Surgeon and community factors affecting breast cancer sentinel lymph node biopsy. Am J Surg (2005) 0.83
Strategies for follow-up and treatment services in state breast and cervical cancer screening programs. Womens Health Issues (1999) 0.78
Social internet sites as a source of public health information. Dermatol Clin (2009) 4.34
Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007. Ann Intern Med (2009) 2.67
Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control (2006) 2.02
Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States). Cancer Causes Control (2006) 1.64
Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States. Am J Obstet Gynecol (2011) 1.51
Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012. Cancer Causes Control (2015) 1.48
MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys (2004) 1.44
Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol (2005) 1.44
Adding over-the-counter dihydroxyacetone self-tanners to sunscreen regimens to increase ultraviolet A light protection. J Am Acad Dermatol (2008) 1.40
HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States. J Acquir Immune Defic Syndr (2002) 1.37
Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers. Prev Med (2013) 1.22
Physician recommendation for papanicolaou testing among U.S. women, 2000. Cancer Epidemiol Biomarkers Prev (2005) 1.22
Cervical cancer screening among young adult women in the United States. Cancer Epidemiol Biomarkers Prev (2013) 1.22
Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med (2011) 1.21
Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012. MMWR Morb Mortal Wkly Rep (2014) 1.21
Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006. Cancer Causes Control (2010) 1.20
Development of a federally funded demonstration colorectal cancer screening program. Prev Chronic Dis (2008) 1.19
Using data to effectively manage a national screening program. Cancer (2014) 1.14
Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United States. Cancer (2011) 1.12
Dual cardiac-respiratory gated PET: implementation and results from a feasibility study. Eur J Nucl Med Mol Imaging (2007) 1.11
A population-based evaluation of cervical screening in the United States: 2008-2011. Cancer Epidemiol Biomarkers Prev (2013) 1.08
Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001. Obstet Gynecol (2004) 1.05
Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programs. Prev Chronic Dis (2008) 1.05
Data sources for identifying low-income, uninsured populations: application to public health-National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 1.03
Explaining variation across grantees in breast and cervical cancer screening proportions in the NBCCEDP. Cancer Causes Control (2015) 1.01
Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005. J Low Genit Tract Dis (2008) 1.01
Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program. J Womens Health (Larchmt) (2012) 0.98
Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998-2012. Cancer Causes Control (2015) 0.98
Impact of the 2002 American society for Colposcopy and Cervical Pathology guidelines on cervical cancer diagnosis in a geographically diverse population of commercially insured women, 1999-2004. J Low Genit Tract Dis (2011) 0.97
National Breast and Cervical Cancer Early Detection Program data validation project. Cancer (2014) 0.96
Timing of colposcopy after cervical cytologic abnormalities. Obstet Gynecol (2010) 0.95
Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program. Cancer (2013) 0.92
Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis. Cancer (2013) 0.92
Repeat pap testing and colposcopic biopsies in the underserved. Obstet Gynecol (2009) 0.90
Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer (2013) 0.90
Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program. Cancer (2008) 0.90
Serum carotenoids and alpha-tocopherol and risk of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev (2004) 0.90
Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012. Cancer Causes Control (2015) 0.88
Breast and cervical cancers diagnosed and stage at diagnosis among women served through the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 0.88
Forward. The reach and health impacts of the national breast and cervical cancer early detection program. Cancer Causes Control (2015) 0.86
A comparative analysis of breast cancer stage between women enrolled in the National Breast and Cervical Cancer Early Detection Program and women not participating in the program. Cancer Causes Control (2015) 0.86
US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening. Sex Health (2010) 0.85
Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts. Cancer (2013) 0.84
Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs. Cancer (2013) 0.84
Choropleth map design for cancer incidence, part 1. Prev Chronic Dis (2009) 0.83
Choropleth map design for cancer incidence, part 2. Prev Chronic Dis (2009) 0.82
Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs. Eval Program Plann (2010) 0.81
A combined approach to women's health is associated with a greater likelihood of repeat mammography in a population of financially disadvantaged women. Prev Chronic Dis (2007) 0.81
News from the CDC: collaborations to build capacity at the community level in cancer prevention and control. Transl Behav Med (2013) 0.80
Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance. Cancer Causes Control (2015) 0.79
Erratum to: Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998-2012. Cancer Causes Control (2015) 0.79
Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program. Cancer (2013) 0.78
Cervical cancer screening measures need to evolve to continue to tell the story. J Womens Health (Larchmt) (2012) 0.75
Using Evidence-Based Interventions to Improve Cancer Screening in the National Breast and Cervical Cancer Early Detection Program. J Public Health Manag Pract (2016) 0.75
Erratum to: Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012. Cancer Causes Control (2015) 0.75
Haematuria. Br J Gen Pract (2002) 0.75
Primary cardiac diffuse, large B-cell lymphoma in an immunocompetent patient. J Invasive Cardiol (2008) 0.75
Erratum to: Data sources for identifying low-income, uninsured populations: application to public health-National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 0.75
Erratum to: Explaining variation across grantees in breast and cervical cancer screening proportions in the NBCCEDP. Cancer Causes Control (2015) 0.75
Erratum to: Breast and cervical cancers diagnosed and stage at diagnosis among women served through the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 0.75
Dermatology information on the Internet: an appraisal by dermatologists and dermatology residents. J Am Acad Dermatol (2010) 0.75
Can high-grade cervical lesions be managed in a single clinic visit? Nat Clin Pract Oncol (2006) 0.75
Content analysis of continuing medical education for cervical cancer screening. J Womens Health (Larchmt) (2010) 0.75
Erratum to: The reach and health impacts of the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 0.75
Erratum to: Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance. Cancer Causes Control (2015) 0.75